Core Viewpoint - The global family care leader, Saint Bella, has officially launched its IPO process, aiming to raise capital in a booming Hong Kong market, with a share price set at HKD 6.58 and a total offering of 95.42 million shares [1][2]. Group 1: Investment Highlights - Saint Bella's IPO has attracted a prestigious lineup of cornerstone investors, including the Hangzhou government-backed Xiaoshan District Industrial Fund, marking a significant regional benchmark [2][6]. - The strategic investment from the high-end private medical group, Harmony Family, is expected to create synergies between its medical resources and Saint Bella's care system, potentially forming a "high-end care + specialized medical" ecosystem [2]. - The participation of major public fund, Huaxia Fund, further underscores the recognition of the company's long-term value by mainstream capital [3]. Group 2: Financial Performance - Saint Bella's revenue has shown robust growth, increasing from CNY 472 million in 2022 to CNY 799 million in 2024, representing a compound annual growth rate (CAGR) of 30.15%, significantly outpacing the industry average [8]. - The adjusted net profit has turned from a loss in 2022 to a profit of CNY 20.77 million in 2023, and is projected to reach CNY 42.26 million in 2024, with a year-on-year growth rate of 103.43% [9]. Group 3: Market Position and Strategy - As the first global family care company to go public, Saint Bella is positioned as a benchmark in the industry, redefining the market landscape [7]. - The company has innovatively developed a comprehensive service ecosystem covering the entire family care cycle, creating strong competitive barriers and first-mover advantages [8]. - The diversified business model, extending from core maternal and infant care to home care and postpartum rehabilitation, is expected to drive significant revenue growth through synergistic effects [8]. Group 4: Capital Market Dynamics - The dual backing of top-tier investment banks, CITIC Securities and UBS, provides strong credibility to Saint Bella's IPO process, with their previous IPOs averaging a first-day increase of 33.3% [4]. - The combination of innovative business models, validated financial data, and strategic resource aggregation positions Saint Bella to redefine the value standards in the global family care industry [11].

Group 1 - The company, Sheng Bella, plans to conduct an IPO from June 18 to June 23, 2025, offering 95.42 million shares at a price of HKD 6.58 per share, with trading expected to commence on June 26, 2025 [1] - Sheng Bella is recognized as the largest postpartum care and recovery group in Asia and China, with a market share of approximately 1.2% based on revenue from maternity centers in 2024 [1] - The company aims to become Asia's leading integrated family care brand group by expanding its service network beyond existing markets in mainland China, Hong Kong, Singapore, and the United States [1] Group 2 - The company has entered into cornerstone investment agreements, with investors agreeing to subscribe for shares totaling up to USD 41.5 million, subject to certain conditions [2] - The estimated net proceeds from the global offering are approximately HKD 541 million, with 29% allocated for expanding the postpartum care network and 37% for launching new services and products [2] - Additional allocations include 6% for training professional family care experts, 18% for research and development activities, and 9% for working capital and other general corporate purposes [2]

聖貝拉有限公司 全球發售 SAINT BELLA Inc. 股份代號：2508 （於開曼群島註冊成立的有限公司） 聯席保薦人︑聯席整體協調人︑ 聯席全球協調人︑ 聯席賬簿管理人及聯席牽頭經辦人 股份代號 ： 2508 聯席保薦人、聯席整體協調人、聯席全球協調人、 聯席賬簿管理人及聯席牽頭經辦人 聖貝拉有限公司 重要提示 重要提示：您對本招股章程任何內容如有任何疑問，應諮詢獨立專業意見。 SAINT BELLA Inc. 聖貝拉有限公司 （於開曼群島註冊成立的有限公司） 全球發售 全球發售的發售股份數目 ： 95,420,000股（視乎發售量調整權及超額配股權 行使與否而定） 香港發售股份數目 ： 9,542,000股（可予重新分配） 國際發售股份數目 ： 85,878,000股（可予重新分配、視乎發售量調整 權及超額配股權行使與否而定） 發售價 ： 每股6.58港元，另加1.0%經紀佣金、0.0027% 證監會交易徵費、0.00565%聯交所交易費及 0.00015%會財局交易徵費（須於申請時以港元繳 足，多繳款項可予退還） 面值 ： 每股0.0001美元 聯席整體協調人、聯席全球協調人、聯席賬簿管理人及聯席 ...

香港交易及結算所有限公司、香港聯合交易所有限公司（「聯交所」）及香港中央結算有限公司 （「香港結算」）對本公告的內容概不負責，對其準確性或完整性亦不發表任何聲明，並明確表 示概不就因本公告全部或任何部分內容而產生或因依賴該等內容而引致的任何損失承擔任 何責任。 本公告不會直接或間接在或向美國（包括其領土及屬地、美國任何州以及哥倫比亞特區）發佈、 刊發或派發。本公告並非亦無意構成或組成於美國或任何其他司法管轄區購買或認購證券的 任何要約或招攬的一部分。發售股份不曾亦不會根據1933年美國《證券法》（經不時修訂）（「美 國《證券法》」）或美國任何州或其他司法管轄區的證券法登記，且不得在美國境內提呈發售、 出售、抵押或轉讓，惟獲豁免遵守或毋須遵守美國《證券法》登記規定及任何適用的州證券法 的交易除外。發售股份將不會於美國進行公開發售。發售股份僅可(1)根據美國《證券法》的登 記豁免向合資格機構買家（定義見美國《證券法》第144A條）；及(2)根據美國《證券法》S規例以 及進行發售及出售的各司法管轄區適用法例在美國境外以離岸交易方式提呈發售及出售。 聖貝拉有限公司 （於開曼群島註冊成立的有限公司） 全球發售 本公告僅 ...